CDASI-A score at 12 weeks was significantly lower in dazukibart 600 mg versus placebo, suggesting reduced morbidity. 2.

Exposures to silica dust, solvents or heavy metals increase the likelihood of developing various forms of myositis, ...

These conditions are commonly misdiagnosed for anxiety when they are really something far more serious than that ...

Among patients with cancer-related dermatomyositis, cancer remission and younger age were associated with dermatomyositis complete clinical response. Cancer remission is crucial for achieving complete ...

Dermatomyositis and lupus may share symptoms in some cases. Here's what you need to know about these autoimmune conditions.

Received FDA orphan drug designation for the treatment of dermatomyositis in April 2017. Received FDA approval for the treatment of dermatomyositis in adults in July 2021. The mechanism of action ...

She started the thread by writing, "I have Tourette Syndrome. As a teenager, my doctor said it was the most severe case she’d ever seen. AMA [Ask Me Anything]. I was diagnosed in my teens (I’m ...

To evaluate the effectiveness, safety, and target engagement of dazukibart (humanized, selective IgG1 neutralizing monoclonal antibody that targets IFNβ) in people with moderate-to-severe ...

Sunburn can be a painful consequence of spending too much time in the sun or a tanning bed. In rare cases, people with sunburn may also experience an extreme, deep, painful itching called hell’s ...

SINGAPORE – The deadly consequences of hoarding were highlighted after a fire in a Hougang flat killed three people on Jan 9. Neighbours had said the family living in the unit were hoarders.

Storm Éowyn will be a “dangerous, destructive” weather event and among the most severe storms Ireland has ever experienced, the chair of the National Emergency Co-ordination Group (NECG) ...

Keith Leonard, chair of the National Emergency Co-ordination Group, warned the “dangerous, destructive” weather event will be among the most severe storms Ireland has ever seen. “It will be ...